Arteris shares surge 11.93% premarket after Altera licenses IP for next-gen FPGA and SoC development.

Arteris Inc. (Nasdaq: AIP) surged 11.93% in premarket trading following its announcement that Altera, the largest independent FPGA solutions provider, licensed its network-on-chip IP and SoC integration automation software for next-generation FPGA and SoC FPGA development. The partnership, involving Arteris' Ncore, FlexGen, and Magillem products, aims to streamline design workflows, optimize data movement, and accelerate time-to-market for Altera’s programmable architectures across data center, communications, and industrial automation applications. This milestone underscores growing demand for Arteris’ technology in high-growth AI and edge computing markets. Additionally, the company’s Q3 2025 earnings report highlighted a 24% year-over-year increase in annual contract value plus royalties ($74.9M) and a 34% rise in remaining performance obligations ($104.7M), reinforcing investor confidence in its strategic positioning amid semiconductor innovation. The Altera deal and robust financial metrics collectively drove the premarket rally.